Rac Exam Practice

A new chemical isintroduced into a manufacturing facility. The regulatory affizirs practitioner must ensure thatwhich ofthe fOllowing documents are availablefOr the chemical? A DOT manifest B. MSDS e. Interstate Bill of Lading D. USP monograph - Answer- B. MSDS A This document is not usually required by the manufacturer B. B. The information contained in the MSDS must be disseminated as mandated by OSHA regulations 29 CFR 1900.1200 (Hazard Communication) and various state "employee right to know" laws. Failure to comply may expose the company to legal risk. C. This document is not usually required by the manufacturer. D. This may contain useful information about certain chemicaJs, but there is no statutory mandate that they be available. When assembling an NDA, all of the following FDA guidelines are used EXCEPT: A. environmental assessment of human drugs and biologics application. B. preparation of an IND product. C. format and content of an application summary. D. format and content of clinical and statistical sections. - Answer- B. preparation of an IND product. A. This is a guidance document that will help the regulatory professional assemble an NDA B. This guidance is useful in describing how to assemble an IND, the phase of drug development that precedes an NDA C.This is a guidance document that will help the regulatory professional assemble an NDA D.This is a guidance document that will help the regulatory professional assemble an NDA Under the IDE regulation, all of the following must be reported to the sponsor within 5 days EXCEPT: A. a deviation from the investigational plan. B. withdrawal of IRB approval. C. an un